Study: Template-Based LND May Aid Local UTUC Control
Template-based lymph node dissection in patients with upper tract urothelial carcinoma could facilitate better local disease control by eliminating micrometastasis, according to investigators.
Template-based lymph node dissection in patients with upper tract urothelial carcinoma could facilitate better local disease control by eliminating micrometastasis, according to investigators.
In a study involving stage 3 RCC patients, those with positive lymph nodes had markedly inferior 5-year survival compared with those with lymph-node negative disease and 5-year survival similar to those with stage 4 RCC.
In the PROSPER study, median overall survival was significantly longer among enzalutamide-treated patients compared with placebo recipients (67.0 vs 56.3 months).
Investigators performed a literature review to better understand how delays in treatment might affect clinical outcomes in urologic cancer patients, including the risk of upstaging, recurrence, and mortality.
A study found no survival differences between high-grade UTUC patients who at the time of radical nephroureterectomy achieved low-grade disease following neoadjuvant chemotherapy and those who had inherently low-stage disease and did not receive chemotherapy.
In a study of T2 to T3 RCC patients, lymph node dissection did not significantly improve overall survival.
Researchers estimated a low excess risk of prostate cancer death for favorable-risk patients undergoing active surveillance rather than surgery: 1.1% to 8.7% over 15 years.
Two-year prostate cancer survival rates only increased from 60% in 2004 to 63% in 2014.
Bladder cuff resection improves survival, according to investigators.
In a study of men with bone metastases from metastatic castration-resistant prostate cancer, black men had no significantly greater risk of skeletal-related events than nonblack men.